angiotensin ii has been researched along with AIDS-Associated Nephropathy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandel, N; Husain, M; Malhotra, A; Mathieson, PW; Rai, P; Saleem, MA; Salhan, D; Sharma, B; Singh, T; Singhal, PC | 1 |
| Hiramatsu, N; Hiromura, K; Ikeuchi, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakurai, N; Shigehara, T; Takeuchi, S; Tomioka, M | 1 |
| Chander, PN; Charney, DN; Ding, G; Kumar, D; Singhal, PC; Vallabu, S; Yadav, A | 1 |
| Bandhlish, A; Chander, PN; Kumar, D; Magoon, S; Malhotra, A; Sagar, A; Salhan, D; Sayeneni, S; Singhal, PC; Torri, DD | 1 |
| Hiramatsu, N; Hiromura, K; Ideura, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakairi, T; Shigehara, T; Takeuchi, S; Tomioka, M; Yamashita, S | 1 |
5 other study(ies) available for angiotensin ii and AIDS-Associated Nephropathy
| Article | Year |
|---|---|
HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor.
Topics: Actins; AIDS-Associated Nephropathy; Angiotensin II; Cathepsin L; Cytoskeleton; Down-Regulation; Gene Expression; HIV Infections; HIV-1; Humans; Oxidative Stress; Podocytes; Receptors, Calcitriol; Renin-Angiotensin System; Transduction, Genetic; Transfection | 2013 |
Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluorescent Antibody Technique; Fluvastatin; Genes, Wilms Tumor; Glomerulosclerosis, Focal Segmental; Immunoenzyme Techniques; Indoles; Kidney; Male; Membrane Proteins; Mice; Mice, Transgenic; Microfilament Proteins; Nephrectomy; Phenotype; Podocytes; Proteinuria | 2009 |
HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.
Topics: Actins; AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cadherins; Calcium-Binding Proteins; Cell Proliferation; Cell Transdifferentiation; Disease Models, Animal; Epithelial Cells; Fibroblasts; HIV-1; Infusions, Subcutaneous; Kidney Glomerulus; Kidney Tubules; Macrophages; Mice; Mice, Transgenic; Phenotype; Podocytes; Proliferating Cell Nuclear Antigen; Receptor, Angiotensin, Type 1; RNA, Messenger; S100 Calcium-Binding Protein A4; S100 Proteins; T-Lymphocytes; Telmisartan | 2010 |
Adverse host factors exacerbate occult HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensinogen; Animals; Biomarkers; Blood Pressure; Connective Tissue Growth Factor; Doxycycline; Epithelial-Mesenchymal Transition; Female; Gene Dosage; Genes, vpr; Host-Pathogen Interactions; Kidney; Male; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A; Phenotype; Proteinuria; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Gene Products, vpr; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Transgenic; Norepinephrine; Phenotype; Podocytes; Receptor, Angiotensin, Type 1 | 2007 |